Deneen Vojta, MD

Evaluation of healthcare utilization and costs over 3 years for adults with insulin-requiring diabetes who transition from multiple daily insulin injections to insulin infusion pumps.

Deneen Vojta, MD, says cheaper, better, more accessible healthcare is something we all want. Big data, value-based insurance design, and value-based contacting are all factors that might help the industry get there.

Dr. Deneen Vojta, UnitedHealthcare, discusses her paper and answers questions at the Healthcare Innovations and HIT Q&A Session at the National Press Club.

Initial experience with the Diabetes Prevention and Control Alliance indicates that large-scale prevention and disease control management programs make economic sense.